Volunteers are given shots of Moderna's Covid-19 vaccine during a trial in Michigan. AFP
Volunteers are given shots of Moderna's Covid-19 vaccine during a trial in Michigan. AFP
Volunteers are given shots of Moderna's Covid-19 vaccine during a trial in Michigan. AFP
Volunteers are given shots of Moderna's Covid-19 vaccine during a trial in Michigan. AFP

Moderna says its vaccine is 94.5 per cent effective in preventing Covid-19


Paul Carey
  • English
  • Arabic

US biotech company Moderna gave new hope for an effective weapon against Covid-19 on Monday by announcing its experimental vaccine was 94.5 per cent effective in preventing the virus.

Moderna is the second US company to report results that far exceed expectations.

A week ago, competitor Pfizer announced its own Covid-19 vaccine appeared similarly effective – news that puts both companies on track to seek permission within weeks for emergency use in the US.

Moderna hailed its Covid-19 vaccine as a potential "game changer".

"We are going to have a vaccine that can stop Covid-19,” said Dr Stephen Hoge, Moderna’s president. He welcomed the “really important milestone” but said having similar results from two different companies is what is most reassuring.

“That should give us all hope that actually a vaccine is going to be able to stop this pandemic and hopefully get us back to our lives,” Dr Hoge said.

“It won’t be Moderna alone that solves this problem. It’s going to require many vaccines” to meet the global demand, he said.

Stéphane Bancel, Moderna's chief executive, said: “This is a pivotal moment in the development of our Covid-19 vaccine candidate. Since early January, we have chased this virus with the intent to protect as many people around the world as possible. All along, we have known that each day matters. This positive interim analysis from our Phase 3 study has given us the first clinical validation that our vaccine can prevent Covid-19 disease, including severe disease.”

Both the Pfizer and Moderna shots rely on a technology called messenger RNA that has never been used to build an approved vaccine. Soon, millions of people around the world could be spared from the illness by the breakthroughs.

A preliminary analysis of data from more than 30,000 volunteers showed Moderna’s vaccine prevented virtually all symptomatic cases of Covid-19, the disease caused by the coronavirus, the company said.

A key advantage of Moderna's vaccine is that it does not need ultra-cold storage like Pfizer's, making it easier to distribute.

We have two vaccines that are really quite effective, so I think this is a really strong step forward

Moderna expects it to be stable at normal fridge temperatures of 2°C to 8°C for 30 days and it can be stored for up to six months at minus 20°C. Pfizer's vaccine must be shipped and stored at minus 70°C, the sort of temperature typical of an Antarctic winter. It can be stored for up to five days at standard refrigerator temperatures or for up to 15 days in a thermal shipping box.

Moderna, part of the US government's Operation Warp Speed programme, expects to produce about 20 million doses of the vaccine for the US this year, millions of which the company has already made, and is ready to ship if it receives FDA authorisation.

"Assuming we get an emergency use authorisation, we'll be ready to ship through Warp Speed almost in hours," Dr Hoge said. "So it could start being distributed instantly."

The UK government has committed to buying 5 million vaccines, which is enough for 2.5 million people.

Hajj inspiration

Lebanese-American virologist Hadi Yassine played a pivotal role in the development of the vaccine.

He fell ill in 2013 after completing the hajj pilgrimage to Makkah.

A nurse prepares a shot of Moderna's vaccine. US equity markets hit record highs on Monday after Moderna announced its Covid-19 vaccine candidate was 94.5 per cent effective. AP Photo
A nurse prepares a shot of Moderna's vaccine. US equity markets hit record highs on Monday after Moderna announced its Covid-19 vaccine candidate was 94.5 per cent effective. AP Photo

The breakneck speed at which the US team was able to roll out a vaccine candidate – the shot was given to the first volunteer during trials after just 63 days – is down to groundbreaking work that the US National Institutes of Health did in 2013 with Dr Yassine and the common coronavirus that returned with him from Makkah.

The team worked on Sars and Mers before turning their attention to other coronaviruses.

The work done by the NIH in 2013 through to 2017 has directly informed the progress that the institutes have made on pandemic preparedness in the run-up to the coronavirus outbreak.

Dr Yassine’s discovery has not only led to the lightning-fast roll-out of the Moderna vaccine trials but is also the science behind about half the other vaccine candidates now in the race to stop Covid-19.

Shares quadruple

Moderna's shares, which have more than quadrupled this year, rose 15 per cent in premarket trading while European stocks and Wall Street stock futures jumped on the vaccine update. The benchmark S&P 500 futures rose 1.3 per cent, stopping just short of a new record high, while the pan-European STOXX 600 hit late-February highs.

"Just as their initial dose of vaccine bullishness appeared to be waning, the markets got another injection of good news this Monday," said Spreadex analyst Connor Campbell.

"One-upping BioNTech and Pfizer, Moderna has claimed its preparation is nearly '95 percent effective' after a trial involving 30,000 Americans.

"As with Pfizer, there is still a way to go before Moderna's vaccine is approved. However, investors were only thinking about the long term, flashing forward to the end of this nightmare."

World oil prices soared by more than 3.5 per cent as the Moderna news stoked hopes of a recovery in energy demand.

Only five participants who received two doses of the vaccine became ill, compared with 90 coronavirus cases in participants who received a placebo, according to a review by an independent data safety monitoring board appointed by the US National Institutes of Health.

The vaccine also appeared to be effective in preventing the most serious Covid-19 infections. There were no severe cases among people who got the vaccine, compared with 11 in volunteers who received placebo shots, according to Moderna.

Volunteers vaccinated

If the US Food and Drug Administration allows emergency use of Moderna’s or Pfizer’s candidates, there will be limited, rationed supplies before the end of the year. Both require people to get two shots, several weeks apart. Moderna expects to have about 20 million doses, earmarked for the US, by the end of 2020. Pfizer and its German partner BioNTech expect to have about 50 million doses globally by the year’s end.

  • Sheikh Abdullah bin Mohammed Al Hamed, chairman of the Department of Health Abu Dhabi, receives a vaccine during a clinical trial for the third phase of the inactive vaccine for Covid-19. Courtesy Wam.
    Sheikh Abdullah bin Mohammed Al Hamed, chairman of the Department of Health Abu Dhabi, receives a vaccine during a clinical trial for the third phase of the inactive vaccine for Covid-19. Courtesy Wam.
  • Sheikh Abdullah bin Mohammed Al Hamed, chairman of Department of Health Abu Dhabi, participates in phase III of the clinical trial for the Covid-19 inactivated vaccine in Abu Dhabi. Courtesy: Abu Dhabi Government Media Office
    Sheikh Abdullah bin Mohammed Al Hamed, chairman of Department of Health Abu Dhabi, participates in phase III of the clinical trial for the Covid-19 inactivated vaccine in Abu Dhabi. Courtesy: Abu Dhabi Government Media Office
  • Peng Xiao, group chief executive of G42, speaks at the announcement of the Covid-19 vaccine trials in Abu Dhabi at Sheikh Khalifa Medical City. Victor Besa / The National
    Peng Xiao, group chief executive of G42, speaks at the announcement of the Covid-19 vaccine trials in Abu Dhabi at Sheikh Khalifa Medical City. Victor Besa / The National
  • Officials at the press conference to announce Phase 3 of the Covid-19 clinical vaccine trial in Abu Dhabi. Victor Besa / The National
    Officials at the press conference to announce Phase 3 of the Covid-19 clinical vaccine trial in Abu Dhabi. Victor Besa / The National
  • Officials at the press conference to announce Phase 3 of the Covid-19 clinical vaccine trial in Abu Dhabi. Victor Besa / The National
    Officials at the press conference to announce Phase 3 of the Covid-19 clinical vaccine trial in Abu Dhabi. Victor Besa / The National

Moderna’s vaccine, created with the National Institutes of Health, is being studied in 30,000 volunteers who received either the real vaccination or a placebo.

The study is continuing, and Moderna acknowledged the protection rate might change as more Covid-19 infections are detected and added to the calculations. Also, it is too soon to know how long protection lasts. Both cautions apply to Pfizer’s vaccine as well.

But Moderna’s independent monitors reported some additional, promising details: all 11 severe Covid-19 cases were among placebo recipients, and there were no significant safety concerns.

The main side effects were fatigue, muscle aches and injection-site pain after the vaccine’s second dose, at rates that Mr Hoge characterised as more common than with flu shots, but on par with others such as the shingles vaccine.

Andrew Hill, senior visiting research fellow in the department of pharmacology at the University of Liverpool, said: "This vaccine would be much easier to transport and administer than the one from Pfizer. Also the preliminary evidence suggests that it can prevent severe Covid-19 disease.

  • A patient is transported outside of Tisch Hospital in New York, US. AFP
    A patient is transported outside of Tisch Hospital in New York, US. AFP
  • Workers build up a outdoor area outside a restaurant in New York, US. AFP
    Workers build up a outdoor area outside a restaurant in New York, US. AFP
  • House members participate in a ceremonial swearing-in ceremony at the state Capitol in Oklahoma City, US. AP
    House members participate in a ceremonial swearing-in ceremony at the state Capitol in Oklahoma City, US. AP
  • Passengers ride a bus along 1st Avenue in Manhattan, New York, US. Reuters
    Passengers ride a bus along 1st Avenue in Manhattan, New York, US. Reuters
  • Luiza Erundina, 85, a candidate for vice-mayor, holds her hand to a man's from inside the "cata voto" (Vote Catcher), a car with a plastic booth, in Sao Paulo, Brazil. Reuters
    Luiza Erundina, 85, a candidate for vice-mayor, holds her hand to a man's from inside the "cata voto" (Vote Catcher), a car with a plastic booth, in Sao Paulo, Brazil. Reuters
  • A healthcare worker administers a nasal swab in El Paso, US. AFP
    A healthcare worker administers a nasal swab in El Paso, US. AFP
  • People walk past a cafe in Melbourne, Australia. Reuters
    People walk past a cafe in Melbourne, Australia. Reuters
  • A woman sanitises the entrance of the Casa San Bernardo hotel, in Rome, Italy. AP
    A woman sanitises the entrance of the Casa San Bernardo hotel, in Rome, Italy. AP
  • A doctor teaches on a mannequin how to treat a coronavirus patient during a training session for nurses at the Nouvel Hopital Civil of Strasbourg, eastern Franc. AP
    A doctor teaches on a mannequin how to treat a coronavirus patient during a training session for nurses at the Nouvel Hopital Civil of Strasbourg, eastern Franc. AP
  • A cyclist rides past a billboard in Hull, UK. Getty
    A cyclist rides past a billboard in Hull, UK. Getty

However, the Moderna vaccine is more expensive and there are fewer doses available in the next year. No vaccine company has enough supplies available to protect everyone in need. We will need all the available vaccines with over 90 per cent efficacy to cover global demand."

Stephen Evans, professor of pharmacoepidemiology at the London School of Hygiene and Tropical Medicine, said: "This announcement is a further encouragement that vaccines will be found to not only have an acceptable efficacy, but an efficacy that is much greater than we had anticipated.

"The range of minor adverse effects reported are unsurprising and typical of almost any vaccine. These reactions tend to be local to where the injection was given and are rarely long-lasting or severe.

"Although they reported efficacy being over 94 per cent, there is statistical uncertainty in this; but based on these data, the likely efficacy will be better than 85 per cent, which would be greater than most scientists would have expected."

Europe testing

The US’s top infectious disease expert said the news “is really quite impressive”.

Dr Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, said that Moderna’s finding, along with similar results from Pfizer last week, “is something that foretells an impact on this outbreak”.

“So now we have two vaccines that are really quite effective, so I think this is a really strong step forward to where we want to be about getting control with this outbreak,” Dr Fauci said.

Eleanor Riley, professor of immunology and infectious disease at the University of Edinburgh, said: "It is likely that vaccines that prevent symptomatic disease will reduce the duration and level of infectiousness, and thus reduce transmission, but we don't yet know if this effect will be large enough to make any meaningful difference to the spread of the virus within communities."

Europe's health regulator said on Monday it had launched a real-time "rolling review" of Moderna's vaccine, following similar reviews of vaccines from Pfizer and AstraZeneca.

How much sugar is in chocolate Easter eggs?
  • The 169g Crunchie egg has 15.9g of sugar per 25g serving, working out at around 107g of sugar per egg
  • The 190g Maltesers Teasers egg contains 58g of sugar per 100g for the egg and 19.6g of sugar in each of the two Teasers bars that come with it
  • The 188g Smarties egg has 113g of sugar per egg and 22.8g in the tube of Smarties it contains
  • The Milky Bar white chocolate Egg Hunt Pack contains eight eggs at 7.7g of sugar per egg
  • The Cadbury Creme Egg contains 26g of sugar per 40g egg
Ten tax points to be aware of in 2026

1. Domestic VAT refund amendments: request your refund within five years

If a business does not apply for the refund on time, they lose their credit.

2. E-invoicing in the UAE

Businesses should continue preparing for the implementation of e-invoicing in the UAE, with 2026 a preparation and transition period ahead of phased mandatory adoption. 

3. More tax audits

Tax authorities are increasingly using data already available across multiple filings to identify audit risks. 

4. More beneficial VAT and excise tax penalty regime

Tax disputes are expected to become more frequent and more structured, with clearer administrative objection and appeal processes. The UAE has adopted a new penalty regime for VAT and excise disputes, which now mirrors the penalty regime for corporate tax.

5. Greater emphasis on statutory audit

There is a greater need for the accuracy of financial statements. The International Financial Reporting Standards standards need to be strictly adhered to and, as a result, the quality of the audits will need to increase.

6. Further transfer pricing enforcement

Transfer pricing enforcement, which refers to the practice of establishing prices for internal transactions between related entities, is expected to broaden in scope. The UAE will shortly open the possibility to negotiate advance pricing agreements, or essentially rulings for transfer pricing purposes. 

7. Limited time periods for audits

Recent amendments also introduce a default five-year limitation period for tax audits and assessments, subject to specific statutory exceptions. While the standard audit and assessment period is five years, this may be extended to up to 15 years in cases involving fraud or tax evasion. 

8. Pillar 2 implementation 

Many multinational groups will begin to feel the practical effect of the Domestic Minimum Top-Up Tax (DMTT), the UAE's implementation of the OECD’s global minimum tax under Pillar 2. While the rules apply for financial years starting on or after January 1, 2025, it is 2026 that marks the transition to an operational phase.

9. Reduced compliance obligations for imported goods and services

Businesses that apply the reverse-charge mechanism for VAT purposes in the UAE may benefit from reduced compliance obligations. 

10. Substance and CbC reporting focus

Tax authorities are expected to continue strengthening the enforcement of economic substance and Country-by-Country (CbC) reporting frameworks. In the UAE, these regimes are increasingly being used as risk-assessment tools, providing tax authorities with a comprehensive view of multinational groups’ global footprints and enabling them to assess whether profits are aligned with real economic activity. 

Contributed by Thomas Vanhee and Hend Rashwan, Aurifer

The National Archives, Abu Dhabi

Founded over 50 years ago, the National Archives collects valuable historical material relating to the UAE, and is the oldest and richest archive relating to the Arabian Gulf.

Much of the material can be viewed on line at the Arabian Gulf Digital Archive - https://www.agda.ae/en

Profile

Company name: Jaib

Started: January 2018

Co-founders: Fouad Jeryes and Sinan Taifour

Based: Jordan

Sector: FinTech

Total transactions: over $800,000 since January, 2018

Investors in Jaib's mother company Alpha Apps: Aramex and 500 Startups

Mercer, the investment consulting arm of US services company Marsh & McLennan, expects its wealth division to at least double its assets under management (AUM) in the Middle East as wealth in the region continues to grow despite economic headwinds, a company official said.

Mercer Wealth, which globally has $160 billion in AUM, plans to boost its AUM in the region to $2-$3bn in the next 2-3 years from the present $1bn, said Yasir AbuShaban, a Dubai-based principal with Mercer Wealth.

Within the next two to three years, we are looking at reaching $2 to $3 billion as a conservative estimate and we do see an opportunity to do so,” said Mr AbuShaban.

Mercer does not directly make investments, but allocates clients’ money they have discretion to, to professional asset managers. They also provide advice to clients.

“We have buying power. We can negotiate on their (client’s) behalf with asset managers to provide them lower fees than they otherwise would have to get on their own,” he added.

Mercer Wealth’s clients include sovereign wealth funds, family offices, and insurance companies among others.

From its office in Dubai, Mercer also looks after Africa, India and Turkey, where they also see opportunity for growth.

Wealth creation in Middle East and Africa (MEA) grew 8.5 per cent to $8.1 trillion last year from $7.5tn in 2015, higher than last year’s global average of 6 per cent and the second-highest growth in a region after Asia-Pacific which grew 9.9 per cent, according to consultancy Boston Consulting Group (BCG). In the region, where wealth grew just 1.9 per cent in 2015 compared with 2014, a pickup in oil prices has helped in wealth generation.

BCG is forecasting MEA wealth will rise to $12tn by 2021, growing at an annual average of 8 per cent.

Drivers of wealth generation in the region will be split evenly between new wealth creation and growth of performance of existing assets, according to BCG.

Another general trend in the region is clients’ looking for a comprehensive approach to investing, according to Mr AbuShaban.

“Institutional investors or some of the families are seeing a slowdown in the available capital they have to invest and in that sense they are looking at optimizing the way they manage their portfolios and making sure they are not investing haphazardly and different parts of their investment are working together,” said Mr AbuShaban.

Some clients also have a higher appetite for risk, given the low interest-rate environment that does not provide enough yield for some institutional investors. These clients are keen to invest in illiquid assets, such as private equity and infrastructure.

“What we have seen is a desire for higher returns in what has been a low-return environment specifically in various fixed income or bonds,” he said.

“In this environment, we have seen a de facto increase in the risk that clients are taking in things like illiquid investments, private equity investments, infrastructure and private debt, those kind of investments were higher illiquidity results in incrementally higher returns.”

The Abu Dhabi Investment Authority, one of the largest sovereign wealth funds, said in its 2016 report that has gradually increased its exposure in direct private equity and private credit transactions, mainly in Asian markets and especially in China and India. The authority’s private equity department focused on structured equities owing to “their defensive characteristics.”

Where to donate in the UAE

The Emirates Charity Portal

You can donate to several registered charities through a “donation catalogue”. The use of the donation is quite specific, such as buying a fan for a poor family in Niger for Dh130.

The General Authority of Islamic Affairs & Endowments

The site has an e-donation service accepting debit card, credit card or e-Dirham, an electronic payment tool developed by the Ministry of Finance and First Abu Dhabi Bank.

Al Noor Special Needs Centre

You can donate online or order Smiles n’ Stuff products handcrafted by Al Noor students. The centre publishes a wish list of extras needed, starting at Dh500.

Beit Al Khair Society

Beit Al Khair Society has the motto “From – and to – the UAE,” with donations going towards the neediest in the country. Its website has a list of physical donation sites, but people can also contribute money by SMS, bank transfer and through the hotline 800-22554.

Dar Al Ber Society

Dar Al Ber Society, which has charity projects in 39 countries, accept cash payments, money transfers or SMS donations. Its donation hotline is 800-79.

Dubai Cares

Dubai Cares provides several options for individuals and companies to donate, including online, through banks, at retail outlets, via phone and by purchasing Dubai Cares branded merchandise. It is currently running a campaign called Bookings 2030, which allows people to help change the future of six underprivileged children and young people.

Emirates Airline Foundation

Those who travel on Emirates have undoubtedly seen the little donation envelopes in the seat pockets. But the foundation also accepts donations online and in the form of Skywards Miles. Donated miles are used to sponsor travel for doctors, surgeons, engineers and other professionals volunteering on humanitarian missions around the world.

Emirates Red Crescent

On the Emirates Red Crescent website you can choose between 35 different purposes for your donation, such as providing food for fasters, supporting debtors and contributing to a refugee women fund. It also has a list of bank accounts for each donation type.

Gulf for Good

Gulf for Good raises funds for partner charity projects through challenges, like climbing Kilimanjaro and cycling through Thailand. This year’s projects are in partnership with Street Child Nepal, Larchfield Kids, the Foundation for African Empowerment and SOS Children's Villages. Since 2001, the organisation has raised more than $3.5 million (Dh12.8m) in support of over 50 children’s charities.

Noor Dubai Foundation

Sheikh Mohammed bin Rashid Al Maktoum launched the Noor Dubai Foundation a decade ago with the aim of eliminating all forms of preventable blindness globally. You can donate Dh50 to support mobile eye camps by texting the word “Noor” to 4565 (Etisalat) or 4849 (du).

The specs: 2019 Audi A8

Price From Dh390,000

Engine 3.0L V6 turbo

Gearbox Eight-speed automatic

Power 345hp @ 5,000rpm

Torque 500Nm @ 1,370rpm

Fuel economy, combined 7.5L / 100km

Know your Camel lingo

The bairaq is a competition for the best herd of 50 camels, named for the banner its winner takes home

Namoos - a word of congratulations reserved for falconry competitions, camel races and camel pageants. It best translates as 'the pride of victory' - and for competitors, it is priceless

Asayel camels - sleek, short-haired hound-like racers

Majahim - chocolate-brown camels that can grow to weigh two tonnes. They were only valued for milk until camel pageantry took off in the 1990s

Millions Street - the thoroughfare where camels are led and where white 4x4s throng throughout the festival

Courses%20at%20Istituto%20Marangoni%2C%20Dubai
%3Cp%3E%3Cstrong%3EUndergraduate%20courses%3C%2Fstrong%3E%3Cbr%3EInterior%20Design%3B%20Product%20Design%3B%20Visual%20Design%3B%20Fashion%20Design%20%26amp%3B%20Accessories%3B%20Fashion%20Styling%20%26amp%3B%20Creative%20Direction%3B%20Fashion%20Business%3B%20Foundation%20in%20Fashion%3B%20Foundation%20in%20Design%3Cbr%3E%3Cstrong%3EProfessional%20courses%3C%2Fstrong%3E%3Cbr%3EFashion%20e-Commerce%20%26amp%3B%20Digital%20Marketing%3B%20Fashion%20Entrepreneurship%3B%20Fashion%20Luxury%20Retail%20and%20Visual%20Merchandising%3Cbr%3E%3Cstrong%3EShort%20courses%3C%2Fstrong%3E%3Cbr%3EFashion%20design%3B%20Fashion%20Image%20%26amp%3B%20Styling%3B%20Fashion%20Trend%20Forecasting%3B%20Interior%20Design%3B%20Digital%20Art%20in%20Fashion%3Cbr%3EMore%20information%20is%20at%20%3Ca%20href%3D%22https%3A%2F%2Fwww.istitutomarangoni.com%2Fen%3Futm_source%3DLocal%26utm_medium%3Dorganic%26utm_campaign%3Dgmb%26utm_content%3Ddubai%22%20target%3D%22_self%22%3Ewww.istitutomarangoni.com%3C%2Fa%3E%3C%2Fp%3E%0A
360Vuz PROFILE

Date started: January 2017
Founder: Khaled Zaatarah 
Based: Dubai and Los Angeles
Sector: Technology 
Size: 21 employees
Funding: $7 million 
Investors: Shorooq Partners, KBW Ventures, Vision Ventures, Hala Ventures, 500Startups, Plug and Play, Magnus Olsson, Samih Toukan, Jonathan Labin

Russia's Muslim Heartlands

Dominic Rubin, Oxford

Results

2pm: Serve U – Maiden (TB) Dh60,000 (Dirt) 1,400m; Winner: Violent Justice, Pat Dobbs (jockey), Doug Watson (trainer)

2.30pm: Al Shafar Investment – Conditions (TB) Dh100,000 (D) 1,400m; Winner: Desert Wisdom, Bernardo Pinheiro, Ahmed Al Shemaili

3pm: Commercial Bank of Dubai – Handicap (TB) Dh68,000 (D) 1,200m; Winner: Fawaareq, Sam Hitchcott, Doug Watson

3.30pm: Shadwell – Rated Conditions (TB) Dh100,000 (D) 1,600m; Winner: Down On Da Bayou, Xavier Ziani, Salem bin Ghadayer

4pm: Dubai Real Estate Centre – Maiden (TB) Dh60,000 (D) 1,600m; Winner: Rakeez, Patrick Cosgrave, Bhupat Seemar

4.30pm: Al Redha Insurance Brokers – Handicap (TB) Dh78,000 (D) 1,800m; Winner: Capla Crusader, Bernardo Pinheiro, Rashed Bouresly

SPECS
%3Cp%3E%3Cstrong%3EEngine%3A%3C%2Fstrong%3E%206-cylinder%203-litre%2C%20with%20petrol%20and%20diesel%20variants%3Cbr%3E%3Cstrong%3ETransmission%3A%20%3C%2Fstrong%3E8-speed%20automatic%3Cbr%3E%3Cstrong%3EPower%3A%3C%2Fstrong%3E%20286hp%20(petrol)%2C%20249hp%20(diesel)%3Cbr%3E%3Cstrong%3ETorque%3A%20%3C%2Fstrong%3E450Nm%20(petrol)%2C%20550Nm%20(diesel)%3Cbr%3E%3Cstrong%3EPrice%3A%20%3C%2Fstrong%3EStarting%20at%20%2469%2C800%3Cbr%3E%3Cstrong%3EOn%20sale%3A%20%3C%2Fstrong%3ENow%3C%2Fp%3E%0A
The biog

Name: Timothy Husband

Nationality: New Zealand

Education: Degree in zoology at The University of Sydney

Favourite book: Lemurs of Madagascar by Russell A Mittermeier

Favourite music: Billy Joel

Weekends and holidays: Talking about animals or visiting his farm in Australia